Medifast Inc
NYSE:MED
Medifast Inc
Cost of Revenue
Medifast Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medifast Inc
NYSE:MED
|
Cost of Revenue
-$157.8m
|
CAGR 3-Years
27%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-8%
|
|
|
Estee Lauder Companies Inc
NYSE:EL
|
Cost of Revenue
-$4.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-7%
|
|
|
Bellring Brands Inc
NYSE:BRBR
|
Cost of Revenue
-$1.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Coty Inc
NYSE:COTY
|
Cost of Revenue
-$2.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
|
Inter Parfums Inc
NASDAQ:IPAR
|
Cost of Revenue
-$525m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
|
|
elf Beauty Inc
NYSE:ELF
|
Cost of Revenue
-$376.2m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Medifast Inc
Glance View
Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.
See Also
What is Medifast Inc's Cost of Revenue?
Cost of Revenue
-157.8m
USD
Based on the financial report for Dec 31, 2024, Medifast Inc's Cost of Revenue amounts to -157.8m USD.
What is Medifast Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-8%
Over the last year, the Cost of Revenue growth was 47%. The average annual Cost of Revenue growth rates for Medifast Inc have been 27% over the past three years , 2% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet